EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanobiotechnology: traditional re-interpreting personalized medicine through targeted therapies and regenerative solutions

Sayantani Chattopadhyay, Arunava Goswami, Moumita Sil

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-08 · 398 (8) · 10025-10048

DOI: 10.1007/s00210-025-04038-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 18.03.2025. Verfasst von Sayantani Chattopadhyay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chennai, 603203, Tamil Nadu, India. Hauptthemen laut MEDLINE: Precision Medicine, Regenerative Medicine, Nanotechnology. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 159 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanobiotechnology is transforming personalized medicine by leveraging the unique properties of nanomaterials to address key challenges in targeted drug delivery, regenerative medicine, and diagnostics. The development of nanocarriers, such as liposomes, polymeric nanoparticles, dendrimers, and metallic nanoparticles, has enabled precise drug delivery with enhanced bioavailability and reduced systemic toxicity. Concurrently, nanostructured scaffolds have advanced regenerative medicine by supporting stem cell differentiation, modulating cellular microenvironments, and enhancing tissue repair. These nanoscale innovations have also led to highly sensitive biosensors and imaging agents, significantly improving early disease detection and biomarker monitoring. Despite these advancements, challenges persist, including nanoparticle-induced cytotoxicity, immunogenicity, scalability issues, and regulatory hurdles requiring extensive evaluation of long-term biocompatibility and pharmacokinetics. Addressing these limitations, recent breakthroughs in AI-assisted nanotechnology and CRISPR-Cas9-mediated gene editing are driving next-generation precision medicine, integrating nanoscale therapeutics with computational approaches to enhance efficacy. Future directions focus on nanorobotics, bioengineered nanovaccines, and theranostic platforms capable of simultaneous diagnosis and treatment, paving the way for real-time, patient-specific interventions. The successful translation of nanomedicine into clinical practice will require interdisciplinary collaboration across nanoscience, bioengineering, and translational medicine to refine nanoparticle functionalization, optimize safety profiles, and ensure equitable access to nanotherapeutics. This review provides a comprehensive overview of these advancements, challenges, and emerging opportunities in nanobiotechnology-driven precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineRegenerative MedicineNanotechnologyHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

Clinical applicationsNanobiotechnologyNanocarriersPersonalized medicineRegenerative therapiesTargeted drug delivery

Autor:innen und Institutionen

  • Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chennai, 603203, Tamil Nadu, India.
  • Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Kolkata, 700108, West Bengal, India. agoswami@isical.ac.in.
  • Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Kolkata, 700108, West Bengal, India. moumitasil20@gmail.com.

Zitieren

APA

Chattopadhyay, S., Goswami, A., & Sil, M. (2025). Nanobiotechnology: traditional re-interpreting personalized medicine through targeted therapies and regenerative solutions. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(8), 10025-10048. https://doi.org/10.1007/s00210-025-04038-6

Vancouver

Chattopadhyay S, Goswami A, Sil M. Nanobiotechnology: traditional re-interpreting personalized medicine through targeted therapies and regenerative solutions. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(8):10025-10048. doi:10.1007/s00210-025-04038-6

BibTeX
@article{Chattopadhyay2025,
  author = {Chattopadhyay, Sayantani and Goswami, Arunava and Sil, Moumita},
  title = {Nanobiotechnology: traditional re-interpreting personalized medicine through targeted therapies and regenerative solutions},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {8},
  pages = {10025--10048},
  doi = {10.1007/s00210-025-04038-6}
}
Kostenlos starten →